ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,338,226 | -32.3% | 662,488 | -1.1% | 0.00% | – |
| Q2 2023 | $1,975,815 | -65.2% | 669,768 | -70.5% | 0.00% | – |
| Q1 2023 | $5,678,647 | -24.2% | 2,271,458 | -3.9% | 0.00% | – |
| Q4 2022 | $7,491,410 | -2.6% | 2,363,221 | -8.8% | 0.00% | – |
| Q3 2022 | $7,695,000 | +1.5% | 2,591,089 | +4.3% | 0.00% | – |
| Q2 2022 | $7,578,000 | -76.8% | 2,484,782 | +2.9% | 0.00% | -100.0% |
| Q1 2022 | $32,604,000 | +1.9% | 2,415,102 | -1.7% | 0.00% | 0.0% |
| Q4 2021 | $31,998,000 | +69.8% | 2,455,684 | +22.2% | 0.00% | 0.0% |
| Q3 2021 | $18,845,000 | -7.7% | 2,008,903 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $20,409,000 | +12.0% | 1,993,048 | +101.2% | 0.00% | 0.0% |
| Q1 2021 | $18,224,000 | -38.9% | 990,449 | +13.7% | 0.00% | 0.0% |
| Q4 2020 | $29,837,000 | +2084.3% | 871,136 | +1077.5% | 0.00% | – |
| Q3 2020 | $1,366,000 | – | 73,984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |